ADA Scientific Sessions 2025 Abstract
Safety and Pharmacokinetics of MBX 1416, a Glucagon-Like Peptide 1 Receptor Antagonist, in Healthy Volunteers—A Phase 1 Randomized Trial
Trial in peopleInterventions
Papers by Kristi L. Schneider
1 result
1 result